Cardinal Health, Inc. (0HTG.L)
USD 149.2
(3.21%)
USD 149.2
(3.21%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 852 Million USD | 226.44% |
| 2023 | 261 Million USD | 128.0% |
| 2022 | -932 Million USD | -252.54% |
| 2021 | 611 Million USD | 116.54% |
| 2020 | -3.69 Billion USD | -370.95% |
| 2019 | 1.36 Billion USD | 432.42% |
| 2018 | 256 Million USD | -80.12% |
| 2017 | 1.28 Billion USD | -9.74% |
| 2016 | 1.42 Billion USD | 17.45% |
| 2015 | 1.21 Billion USD | 4.2% |
| 2014 | 1.16 Billion USD | 249.1% |
| 2013 | 334 Million USD | -68.76% |
| 2012 | 1.06 Billion USD | 11.47% |
| 2011 | 959 Million USD | 49.33% |
| 2010 | 642.2 Million USD | -44.23% |
| 2009 | 1.15 Billion USD | -11.46% |
| 2008 | 1.3 Billion USD | -32.65% |
| 2007 | 1.93 Billion USD | 93.09% |
| 2006 | 1 Billion USD | -4.82% |
| 2005 | 1.05 Billion USD | -28.74% |
| 2004 | 1.47 Billion USD | 4.89% |
| 2003 | 1.4 Billion USD | 33.1% |
| 2002 | 1.05 Billion USD | 23.19% |
| 2001 | 857.4 Million USD | 26.14% |
| 2000 | 679.7 Million USD | 48.96% |
| 1999 | 456.3 Million USD | 84.66% |
| 1998 | 247.1 Million USD | 36.44% |
| 1997 | 181.1 Million USD | 61.84% |
| 1996 | 111.9 Million USD | 31.65% |
| 1995 | 85 Million USD | 142.17% |
| 1994 | 35.1 Million USD | 4.46% |
| 1993 | 33.6 Million USD | 33.33% |
| 1992 | 25.2 Million USD | 44.83% |
| 1991 | 17.4 Million USD | 35.94% |
| 1990 | 12.8 Million USD | 45.45% |
| 1989 | 8.8 Million USD | 33.33% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 353 Million USD | 6960.0% |
| 2024 Q1 | 5 Million USD | 107.81% |
| 2024 Q3 | 258 Million USD | -26.91% |
| 2024 FY | 852 Million USD | 226.44% |
| 2024 Q4 | 236 Million USD | -8.53% |
| 2023 Q4 | -64 Million USD | -118.55% |
| 2023 Q1 | 110 Million USD | -20.29% |
| 2023 FY | 261 Million USD | 128.0% |
| 2023 Q2 | -130 Million USD | -218.18% |
| 2023 Q3 | 345 Million USD | 365.38% |
| 2022 Q1 | 271 Million USD | 133.62% |
| 2022 FY | -932 Million USD | -252.54% |
| 2022 Q4 | 138 Million USD | 109.93% |
| 2022 Q3 | -1.39 Billion USD | -2936.73% |
| 2022 Q2 | 49 Million USD | -81.92% |
| 2021 FY | 611 Million USD | 116.54% |
| 2021 Q3 | 119 Million USD | -81.08% |
| 2021 Q2 | 629 Million USD | 348.62% |
| 2021 Q1 | -253 Million USD | -138.57% |
| 2021 Q4 | 116 Million USD | -2.52% |
| 2020 Q1 | -4.92 Billion USD | -2637.11% |
| 2020 FY | -3.69 Billion USD | -370.95% |
| 2020 Q2 | 220 Million USD | 104.47% |
| 2020 Q3 | 350 Million USD | 59.09% |
| 2020 Q4 | 656 Million USD | 87.43% |
| 2019 FY | 1.36 Billion USD | 432.42% |
| 2019 Q3 | 296 Million USD | 5.71% |
| 2019 Q2 | 280 Million USD | -52.78% |
| 2019 Q1 | 593 Million USD | 150.86% |
| 2019 Q4 | 194 Million USD | -34.46% |
| 2018 Q2 | 1.05 Billion USD | 815.65% |
| 2018 Q4 | -1.16 Billion USD | -557.25% |
| 2018 Q1 | 115 Million USD | -58.03% |
| 2018 Q3 | 255 Million USD | -75.78% |
| 2018 FY | 256 Million USD | -80.12% |
| 2017 FY | 1.28 Billion USD | -9.74% |
| 2017 Q3 | 381 Million USD | 17.59% |
| 2017 Q4 | 274 Million USD | -28.08% |
| 2017 Q2 | 324 Million USD | 4.85% |
| 2017 Q1 | 309 Million USD | -7.21% |
| 2016 Q1 | 383 Million USD | 29.83% |
| 2016 Q2 | 326 Million USD | -14.88% |
| 2016 Q3 | 386 Million USD | 18.4% |
| 2016 Q4 | 333 Million USD | -13.73% |
| 2016 FY | 1.42 Billion USD | 17.45% |
| 2015 Q3 | 365 Million USD | 26.3% |
| 2015 FY | 1.21 Billion USD | 4.2% |
| 2015 Q1 | 266 Million USD | 13.68% |
| 2015 Q2 | 289 Million USD | 8.65% |
| 2015 Q4 | 295 Million USD | -19.18% |
| 2014 FY | 1.16 Billion USD | 249.1% |
| 2014 Q3 | 315 Million USD | 13.31% |
| 2014 Q2 | 278 Million USD | -17.99% |
| 2014 Q4 | 234 Million USD | -25.71% |
| 2014 Q1 | 339 Million USD | 157.85% |
| 2013 FY | 334 Million USD | -68.76% |
| 2013 Q4 | -586 Million USD | -269.86% |
| 2013 Q3 | 345 Million USD | 13.86% |
| 2013 Q2 | 303 Million USD | 11.81% |
| 2013 Q1 | 271 Million USD | 14.83% |
| 2012 FY | 1.06 Billion USD | 11.47% |
| 2012 Q4 | 236 Million USD | -29.21% |
| 2012 Q3 | 333.4 Million USD | 27.25% |
| 2012 Q2 | 262 Million USD | 10.64% |
| 2012 Q1 | 236.8 Million USD | 16.82% |
| 2011 Q3 | 246 Million USD | 14.21% |
| 2011 Q2 | 215.4 Million USD | -26.93% |
| 2011 FY | 959 Million USD | 49.33% |
| 2011 Q4 | 202.7 Million USD | -17.6% |
| 2011 Q1 | 294.8 Million USD | 31.9% |
| 2010 FY | 642.2 Million USD | -44.23% |
| 2010 Q2 | 234.5 Million USD | 713.87% |
| 2010 Q4 | 223.5 Million USD | 0.49% |
| 2010 Q3 | 222.4 Million USD | -5.16% |
| 2010 Q1 | -38.2 Million USD | -113.98% |
| 2009 Q4 | 273.2 Million USD | -12.69% |
| 2009 FY | 1.15 Billion USD | -11.46% |
| 2009 Q2 | 318.9 Million USD | 28.02% |
| 2009 Q3 | 312.9 Million USD | -1.88% |
| 2009 Q1 | 249.1 Million USD | -21.67% |
| 2008 Q3 | 356 Million USD | 9.64% |
| 2008 Q2 | 324.7 Million USD | 7.59% |
| 2008 Q4 | 318 Million USD | -10.67% |
| 2008 FY | 1.3 Billion USD | -32.65% |
| 2008 Q1 | 301.8 Million USD | -66.55% |
| 2007 Q1 | 270.7 Million USD | -15.67% |
| 2007 Q2 | 739.3 Million USD | 173.11% |
| 2007 Q3 | 19 Million USD | -97.43% |
| 2007 FY | 1.93 Billion USD | 93.09% |
| 2007 Q4 | 902.2 Million USD | 4648.42% |
| 2006 Q1 | 228.3 Million USD | -11.41% |
| 2006 FY | 1 Billion USD | -4.82% |
| 2006 Q4 | 321 Million USD | 118.66% |
| 2006 Q3 | 146.8 Million USD | -51.71% |
| 2006 Q2 | 304 Million USD | 33.16% |
| 2005 Q3 | 365.8 Million USD | 70.93% |
| 2005 Q2 | 214 Million USD | 0.33% |
| 2005 Q1 | 213.3 Million USD | -37.63% |
| 2005 FY | 1.05 Billion USD | -28.74% |
| 2005 Q4 | 257.7 Million USD | -29.55% |
| 2004 Q2 | 375.8 Million USD | 14.36% |
| 2004 Q1 | 328.6 Million USD | -10.44% |
| 2004 Q3 | 428.1 Million USD | 13.92% |
| 2004 FY | 1.47 Billion USD | 4.89% |
| 2004 Q4 | 342 Million USD | -20.11% |
| 2003 FY | 1.4 Billion USD | 33.1% |
| 2003 Q4 | 366.9 Million USD | -4.23% |
| 2003 Q1 | 288.3 Million USD | -2.7% |
| 2003 Q2 | 367.5 Million USD | 27.47% |
| 2003 Q3 | 383.1 Million USD | 4.24% |
| 2002 Q4 | 296.3 Million USD | -1.33% |
| 2002 Q3 | 300.3 Million USD | 6.0% |
| 2002 Q2 | 283.3 Million USD | 60.69% |
| 2002 Q1 | 176.3 Million USD | -30.4% |
| 2002 FY | 1.05 Billion USD | 23.19% |
| 2001 Q4 | 253.3 Million USD | 31.31% |
| 2001 Q2 | 209.2 Million USD | 20.79% |
| 2001 Q3 | 192.9 Million USD | -7.79% |
| 2001 Q1 | 173.2 Million USD | -11.04% |
| 2001 FY | 857.4 Million USD | 26.14% |
| 2000 Q1 | 122 Million USD | -18.34% |
| 2000 Q4 | 194.7 Million USD | 2.74% |
| 2000 FY | 679.7 Million USD | 48.96% |
| 2000 Q3 | 189.5 Million USD | 9.22% |
| 2000 Q2 | 173.5 Million USD | 42.21% |
| 1999 Q2 | 99.7 Million USD | 72.49% |
| 1999 Q3 | 81.9 Million USD | -17.85% |
| 1999 Q4 | 149.4 Million USD | 82.42% |
| 1999 FY | 456.3 Million USD | 84.66% |
| 1999 Q1 | 57.8 Million USD | -18.13% |
| 1998 Q2 | 66.2 Million USD | 22.14% |
| 1998 Q4 | 70.6 Million USD | 25.4% |
| 1998 FY | 247.1 Million USD | 36.44% |
| 1998 Q1 | 54.2 Million USD | -12.44% |
| 1998 Q3 | 56.3 Million USD | -14.95% |
| 1997 Q4 | 61.9 Million USD | 70.99% |
| 1997 Q3 | 36.2 Million USD | -5.97% |
| 1997 Q1 | 39.8 Million USD | 20.97% |
| 1997 Q2 | 38.5 Million USD | -3.27% |
| 1997 FY | 181.1 Million USD | 61.84% |
| 1996 Q1 | 20.5 Million USD | -7.66% |
| 1996 Q3 | 36.8 Million USD | 96.79% |
| 1996 Q2 | 18.7 Million USD | -8.78% |
| 1996 Q4 | 32.9 Million USD | -10.6% |
| 1996 FY | 111.9 Million USD | 31.65% |
| 1995 Q4 | 22.2 Million USD | -14.29% |
| 1995 Q1 | 16 Million USD | -3.61% |
| 1995 Q3 | 25.9 Million USD | 23.92% |
| 1995 Q2 | 20.9 Million USD | 30.63% |
| 1995 FY | 85 Million USD | 142.17% |
| 1994 FY | 35.1 Million USD | 4.46% |
| 1994 Q1 | 9.2 Million USD | 17.95% |
| 1994 Q3 | -8.9 Million USD | -181.65% |
| 1994 Q2 | 10.9 Million USD | 18.48% |
| 1994 Q4 | 16.6 Million USD | 286.52% |
| 1993 Q1 | 8.9 Million USD | 45.9% |
| 1993 FY | 33.6 Million USD | 33.33% |
| 1993 Q4 | 7.8 Million USD | -26.42% |
| 1993 Q3 | 10.6 Million USD | 32.5% |
| 1993 Q2 | 8 Million USD | -10.11% |
| 1992 Q2 | 6.5 Million USD | 22.64% |
| 1992 Q3 | 8.6 Million USD | 32.31% |
| 1992 FY | 25.2 Million USD | 44.83% |
| 1992 Q1 | 5.3 Million USD | 8.16% |
| 1992 Q4 | 6.1 Million USD | -29.07% |
| 1991 Q2 | 4.5 Million USD | 21.62% |
| 1991 Q4 | 4.9 Million USD | -16.95% |
| 1991 Q1 | 3.7 Million USD | 12.12% |
| 1991 Q3 | 5.9 Million USD | 31.11% |
| 1991 FY | 17.4 Million USD | 35.94% |
| 1990 Q3 | 4.3 Million USD | 30.3% |
| 1990 FY | 12.8 Million USD | 45.45% |
| 1990 Q1 | 4.3 Million USD | 0.0% |
| 1990 Q4 | 3.3 Million USD | -23.26% |
| 1990 Q2 | 3.3 Million USD | -23.26% |
| 1989 FY | 8.8 Million USD | 33.33% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 722.42% |
| Accuray Incorporated | -15.54 Million USD | 5580.862% |
| Align Technology, Inc. | 445.05 Million USD | -91.438% |
| Elevance Health Inc. | 5.98 Billion USD | 85.769% |
| AxoGen, Inc. | -21.71 Million USD | 4023.374% |
| Boston Scientific Corporation | 1.59 Billion USD | 46.516% |
| CVS Health Corporation | 8.34 Billion USD | 89.789% |
| Centene Corporation | 2.7 Billion USD | 68.468% |
| DaVita Inc. | 691.53 Million USD | -23.204% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 83.747% |
| Hologic, Inc. | 789.5 Million USD | -7.916% |
| Humana Inc. | 2.48 Billion USD | 65.769% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -0.823% |
| Laboratory Corporation of America Holdings | 418 Million USD | -103.828% |
| Masimo Corporation | 81.5 Million USD | -945.399% |
| McKesson Corporation | 3 Billion USD | 71.619% |
| Patterson Companies, Inc. | 185.93 Million USD | -358.235% |
| Quest Diagnostics Incorporated | 854 Million USD | 0.234% |
| ResMed Inc. | 1.02 Billion USD | 16.548% |
| Henry Schein, Inc. | 416 Million USD | -104.808% |
| Teladoc Health, Inc. | -220.36 Million USD | 486.626% |
| Universal Health Services, Inc. | 717.79 Million USD | -18.697% |
| Veeva Systems Inc. | 525.7 Million USD | -62.068% |
| Baxter International Inc. | 2.65 Billion USD | 67.922% |
| Becton, Dickinson and Company | 1.48 Billion USD | 42.588% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 52.614% |
| Danaher Corporation | 4.2 Billion USD | 79.714% |
| Stryker Corporation | 3.16 Billion USD | 73.081% |
| Medtronic plc | 3.67 Billion USD | 76.823% |